Funding Opportunities

• NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
  (PAR-18-880)
  National Cancer Institute
  Application Receipt Date(s): November 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Not Allowed)
  (PAR-18-881)
  Office of Behavioral and Social Sciences Research
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): July 12, 2019; July 12, 2020;, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Required)
  (PAR-18-882)
  Office of Behavioral and Social Sciences Research
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): July 12, 2019; July 12, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
  (PAR-18-884)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): December 4, 2018, December 4, 2019, December 4, 2020, December 6, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
  (PAR-18-885)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): December 4, 2018, December 4, 2019, December 4, 2020, December 6, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)
  (PAR-18-886)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 1, 2018; May 30, 2019; October 31, 2019; June 2, 2020; November 3, 2020; June 1, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
  (PAR-18-887)
  National Cancer Institute
  Application Receipt Date(s): January 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
  (PAR-18-888)
  National Cancer Institute
  Application Receipt Date(s): January 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed)
  (PAR-18-889)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed)
  (PAR-18-890)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is November 5, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)
  (RFA-AG-19-010)
  National Institute on Aging
  Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Genomic Innovator Award (R35 Clinical Trial Optional)
  (RFA-HG-18-006)
  National Human Genome Research Institute
  Application Receipt Date(s): October 30, 2018; October 30, 2019; October 30, 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
  (RFA-HL-18-030)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
  (RFA-HL-18-031)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed)
  (RFA-HL-18-033)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 19, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed)
  (RFA-HL-18-035)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
  (RFA-HL-19-005)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Required - Infrastructure)
  (RFA-HL-19-006)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
  (RFA-MD-18-009)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): October 1, 2018), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
  (RFA-MD-18-010)
  National Institute on Minority Health and Health Disparities
  National Institute of Mental Health
  Application Receipt Date(s): April 1, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
  (RFA-MH-19-135)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Application Receipt Date(s): October 9, 2018; September 26, 2019 and September 28, 2020, and May 27, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01 Clinical Trial Optional)
  (RFA-MH-19-150)
  National Institute of Mental Health
  Application Receipt Date(s): November 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Early Psychosis Intervention Network (EPINET): Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-MH-19-151)
  National Institute of Mental Health
  Application Receipt Date(s): November 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
  (RFA-NS-18-041)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Nursing Research
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.